DAVITA INC. Cash and Restricted Cash
DAVITA INC. (DVA) had Cash and Restricted Cash of $751.86 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-04
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $751.86M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $726.40M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $757.75M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $795.41M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $751.86M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $726.40M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $757.75M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $795.41M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $796.96M 10-Q · filed 2026-08-04 |
| 2025-03-31 | $524.57M 10-Q · filed 2026-05-05 |
| 2024-12-31 | $879.83M 10-Q · filed 2026-08-04 |
| 2024-09-30 | $1.16B 10-Q · filed 2025-10-29 |
| 2024-06-30 | $503.25M 10-Q · filed 2025-08-05 |
| 2024-03-31 | $430.78M 10-Q · filed 2025-05-12 |
| 2023-12-31 | $464.63M 10-K · filed 2026-02-11 |
| 2023-09-30 | $545.13M 10-Q · filed 2024-10-29 |
| 2023-06-30 | $422.17M 10-Q · filed 2024-08-06 |
| 2023-03-31 | $411.40M 10-Q · filed 2024-05-02 |
| 2022-12-31 | $338.99M 10-K · filed 2026-02-11 |
| 2022-09-30 | $462.21M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $355.74M 10-Q · filed 2023-08-03 |
| 2022-03-31 | $420.58M 10-Q · filed 2023-05-08 |
| 2021-12-31 | $554.96M 10-K · filed 2025-02-13 |
| 2021-09-30 | $1.14B 10-Q · filed 2022-10-31 |
| 2021-06-30 | $1.21B 10-Q · filed 2022-08-01 |
| 2021-03-31 | $1.06B 10-Q · filed 2022-05-05 |
| 2020-12-31 | $501.79M 10-K · filed 2024-02-14 |
| 2020-09-30 | $817.34M 10-Q · filed 2021-10-28 |
| 2020-06-30 | $3.04B 10-Q · filed 2021-08-03 |
| 2020-03-31 | $1.49B 10-Q · filed 2021-04-29 |
| 2019-12-31 | $1.21B 10-K · filed 2023-02-22 |
| 2019-09-30 | $1.36B 10-Q · filed 2020-10-29 |
| 2019-06-30 | $3.68B 10-Q · filed 2020-07-30 |
| 2019-03-31 | $561.43M 10-Q · filed 2020-05-05 |
| 2018-12-31 | $415.42M 10-K · filed 2022-02-11 |
| 2018-09-30 | $540.15M 10-Q · filed 2019-11-07 |
| 2018-06-30 | $480.15M 10-Q · filed 2019-08-02 |
| 2018-03-31 | $447.62M 10-Q · filed 2019-05-07 |
| 2017-12-31 | $518.92M 10-K · filed 2021-02-12 |
| 2017-09-30 | $538.99M 10-Q · filed 2018-11-07 |
| 2017-06-30 | $453.21M 10-Q · filed 2018-08-01 |
| 2017-03-31 | $1.22B 10-Q · filed 2018-05-03 |
| 2016-12-31 | $683.46M 10-K · filed 2020-02-21 |
| 2015-12-31 | $1.24B 10-K · filed 2019-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |